Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

  • First published: 12 June 2024
  • Last modified: 12 June 2024
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-043b0e
Published by:
NHS England
Authority ID:
AA20005
Publication date:
12 June 2024
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024<br/><br/>Offer reference number: CM/PHS/22/5661<br/><br/>Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months.<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

NHS England

1st Floor, Quarry House, Quarry Hill

Leeds

LS2 7UE

UK

Contact person: Katie Noonan

E-mail: katie.noonan@nhs.net

NUTS: UKE

Internet address(es)

Main address: https://www.england.nhs.uk//

Address of the buyer profile: https://www.england.nhs.uk//

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

Reference number: CM/PHS/22/5661

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024<br/><br/>Offer reference number: CM/PHS/22/5661<br/><br/>Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months.<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

II.1.6) Information about lots

This contract is divided into lots: Yes

II.1.7) Total value of the procurement

Value excluding VAT: 1 080 000 000.00  GBP

II.2) Description

Lot No: 1

II.2.1) Title

CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

Standard Half-life Recombinant Factor VIII

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 3

II.2.1) Title

CM/PHS/22/5661/03 Emicizumab

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/03 Emicizumab

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 4

II.2.1) Title

CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL)

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL)

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 5

II.2.1) Title

CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL)

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL)

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 6

II.2.1) Title

CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL)

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL)

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 7

II.2.1) Title

CM/PHS/22/5661/07 rFIX - Standard Half Life

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/07 rFIX - Standard Half Life

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 8

II.2.1) Title

CM/PHS/22/5661/08 Recombinant Factor VII

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/08 Recombinant Factor VII

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 9

II.2.1) Title

CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 10

II.2.1) Title

CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 11

II.2.1) Title

CM/PHS/22/5661/11 Factor IX - High Purity Factor IX

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/11 Factor IX - High Purity Factor IX

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 12

II.2.1) Title

CM/PHS/22/5661/12 Factor X

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/12 Factor X

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 13

II.2.1) Title

CM/PHS/22/5661/13 Factor XIII - Plasma Derived

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/13 Factor XIII - Plasma Derived

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 14

II.2.1) Title

CM/PHS/22/5661/14 Factor XIII - Recombinant

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/14 Factor XIII - Recombinant

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 15

II.2.1) Title

CM/PHS/22/5661/15 Von willebrands factor / Factor VIII

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/15 Von willebrands factor / Factor VIII

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 16

II.2.1) Title

CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 17

II.2.1) Title

CM/PHS/22/5661/17 Von willebrands factor - Recombinant

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/17 Von willebrands factor - Recombinant

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 18

II.2.1) Title

CM/PHS/22/5661/18 Fibrinogen Concentrate

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/18 Fibrinogen Concentrate

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 19

II.2.1) Title

CM/PHS/22/5661/19 Prothrombin Complex dried

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/19 Prothrombin Complex dried

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 20

II.2.1) Title

CM/PHS/22/5661/20 Protein C Concentrate

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/20 Protein C Concentrate

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 21

II.2.1) Title

CM/PHS/22/5661/21 Fresh Frozen Plasma (all blood groups)

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5561/21 Fresh Frozen Plasma (all blood groups)

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 22

II.2.1) Title

CM/PHS/22/5661/22 Freeze Dried Plasma

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/22 Freeze Dried Plasma

II.2.5) Award criteria

Quality criterion: Ease of Use / Weighting: 10%

Quality criterion: Security of Supply / Weighting: 15%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 23

II.2.1) Title

CM/PHS/22/5661/23 Caplacizumab

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/PHS/22/5661/23 Caplacizumab

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 15%

Quality criterion: Ease of Use / Weighting: 10%

Price / Weighting:  75%

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2024/S 000-005350

Section V: Award of contract

Lot No: 1

Title: Standard Half-life Recombinant Factor VIII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Pfizer Ltd

100674

Walton Oaks, Dorking Road, Walton-on-the-Hill, Tadworth,

Surrey,

KT20 7NS

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Standard Half-life Recombinant Factor VIII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Takeda UK Ltd

03362860

1 Kingdom Street,

London

W2 6BD

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Standard Half-life Recombinant Factor VIII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Octapharma Limited

526209

Glassworks House, 32 Shudehill,

Manchester,

M4 1EZ

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 2

Title: Enhanced Half-life Recombinant Factor VIII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 1

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Novo Nordisk

02372699

3 City Place. Beehive Ring Road.

Gatwick. West Sussex

RH6 0PA

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 2

Title: Enhanced Half-life Recombinant Factor VIII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 1

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Sobi (Swedish Orphan Biovitrum Ltd)

03362860

Swedish Orphan Biovitrum Ltd, Suite 2, Riverside 3, Great Abington,

Cambridgeshire.

CB21 6AD

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 3

Title: Emicizumab

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Roche Products Ltd

04369760

Hexagon Place, Falcon Way, Shire Park,

Welwyn Garden City

AL7 1TW

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 4

Title: Eftrenonacog alfa (rFIX EHL)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 1

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Sobi (Swedish Orphan Biovitrum Ltd)

03362860

Swedish Orphan Biovitrum Ltd, Suite 2, Riverside 3, Great Abington,

Cambridgeshire.

CB21 6AD

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 5

Title: albutrepenonacog alfa (rFIX EHL)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

CSL Behring UK Ltd

01622483

4 Milton Road Haywards Heath

West Sussex

RH16 1AH

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 6

Title: nonacog beta pegol (rFIX EHL)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Novo Nordisk

02372699

3 City Place. Beehive Ring Road.

Gatwick. West Sussex

RH6 0PA

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 7

Title: rFIX - Standard Half Life

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Pfizer Ltd

100674

Walton Oaks, Dorking Road, Walton-on-the-Hill, Tadworth,

Surrey,

KT20 7NS

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 7

Title: rFIX - Standard Half Life

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Takeda UK Ltd

03362860

1 Kingdom Street,

London

W2 6BD

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 8

Title: Recombinant Factor VII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Novo Nordisk

02372699

3 City Place. Beehive Ring Road.

Gatwick. West Sussex

RH6 0PA

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 8

Title: Recombinant Factor VII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

LFB

01118740

LFB Biopharmaceuticals Limited, Suite 104, Spirella Building, Bridge Road, Letchworth Garden City,

Hertfordshire,

SG6 4ET.

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 9

Title: Porcine Factor VIII - susoctocog alfa

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Takeda UK Ltd

03362860

1 Kingdom Street,

London

W2 6BD

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 10

Title: Factor VIII Inhibitor Bypassing Fraction

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Takeda UK Ltd

03362860

1 Kingdom Street,

London

W2 6BD

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 11

Title: Factor IX - High Purity Factor IX

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Bio Products Laboratory Ltd

07343036

Dagger Lane,

Elstree, Hertfordshire

WD6 3BX

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 12

Title: Factor X

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Bio Products Laboratory Ltd

07343036

Dagger Lane,

Elstree, Hertfordshire

WD6 3BX

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 13

Title: Factor XIII - Plasma Derived

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

CSL Behring UK Ltd

01622483

4 Milton Road Haywards Heath

West Sussex

RH16 1AH

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 14

Title: Factor XIII - Recombinant

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Novo Nordisk

02372699

3 City Place. Beehive Ring Road.

Gatwick. West Sussex

RH6 0PA

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 15

Title: Von willebrands factor / Factor VIII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Octapharma Limited

526209

Glassworks House, 32 Shudehill,

Manchester,

M4 1EZ

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 15

Title: Von willebrands factor / Factor VIII

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

CSL Behring UK Ltd

01622483

4 Milton Road Haywards Heath

West Sussex

RH16 1AH

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 16

Title: Von willebrands factor - Plasma Derived

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

LFB

01118740

LFB Biopharmaceuticals Limited, Suite 104, Spirella Building, Bridge Road, Letchworth Garden City,

Hertfordshire,

SG6 4ET.

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 17

Title: Von willebrands factor - Recombinant

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Takeda UK Ltd

03362860

1 Kingdom Street,

London

W2 6BD

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 18

Title: Fibrinogen Concentrate

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

LFB

01118740

LFB Biopharmaceuticals Limited, Suite 104, Spirella Building, Bridge Road, Letchworth Garden City,

Hertfordshire,

SG6 4ET.

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 18

Title: Fibrinogen Concentrate

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Octapharma Limited

526209

Glassworks House, 32 Shudehill,

Manchester,

M4 1EZ

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 18

Title: Fibrinogen Concentrate

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

CSL Behring UK Ltd

01622483

4 Milton Road Haywards Heath

West Sussex

RH16 1AH

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 19

Title: Prothrombin Complex dried

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Takeda UK Ltd

03362860

1 Kingdom Street,

London

W2 6BD

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 19

Title: Prothrombin Complex dried

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Octapharma Limited

526209

Glassworks House, 32 Shudehill,

Manchester,

M4 1EZ

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 19

Title: Prothrombin Complex dried

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 3

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

CSL Behring UK Ltd

01622483

4 Milton Road Haywards Heath

West Sussex

RH16 1AH

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 20

Title: Protein C Concentrate

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Takeda UK Ltd

03362860

1 Kingdom Street,

London

W2 6BD

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 21

Title: Fresh Frozen Plasma (all blood groups)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

31/05/2024

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Octapharma Limited

526209

Glassworks House, 32 Shudehill,

Manchester,

M4 1EZ

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 22

Title: Freeze Dried Plasma

A contract/lot is awarded: No

V.1 Information on non-award

The contract/lot is not awarded

No tenders or requests to participate were received or all were rejected

Section V: Award of contract

Lot No: 23

Title: Caplacizumab

A contract/lot is awarded: No

V.1 Information on non-award

The contract/lot is not awarded

No tenders or requests to participate were received or all were rejected

Section VI: Complementary information

VI.3) Additional information

This award notice and related ITO documentation was initially advertised under the tender reference CM/PHS/22/5561, however this was a typo. <br/>Award documentation and subsequent notices reflect the correct tender reference of CM/PHS/22/5661.

VI.4) Procedures for review

VI.4.1) Review body

The High Court

The Strand

London

WC2A 2LL

UK

Internet address(es)

URL: https://www.judiciary.uk/courts-and-tribunals/high-court/

VI.5) Date of dispatch of this notice

11/06/2024

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
katie.noonan@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.